Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection

Halil Ozdemir; Ergin Çiftçi; Elif Unal Ince; Mehmet Ertem; Erdal Ince; Ulker Doğru

doi:10.1097/MPH.0b013e3181f46baf

Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection

J Pediatr Hematol Oncol. 2011 Mar;33(2):135-7. doi: 10.1097/MPH.0b013e3181f46baf.

Authors

Halil Ozdemir¹, Ergin Çiftçi, Elif Unal Ince, Mehmet Ertem, Erdal Ince, Ulker Doğru

Affiliation

¹ Department of Pediatric Infectious Diseases, Faculty of Medicine, Ankara University, Ankara, Turkey. [email protected]

PMID: 21285906
DOI: 10.1097/MPH.0b013e3181f46baf

Abstract

Hemophagocytic lymphohistiocytosis (HLH) has not been described earlier in the context of 2009 pandemic influenza A (H1N1) virus infection, although certain populations are thought to be at risk for complicated pandemic influenza A disease. Here, we report the second case of HLH after infection with the influenza A H1N1 virus treated with peroral oseltamivir successfully.

Publication types

Case Reports

MeSH terms

Antiviral Agents / therapeutic use
Humans
Infant
Influenza A Virus, H1N1 Subtype / physiology*
Influenza, Human / complications*
Influenza, Human / drug therapy
Influenza, Human / epidemiology*
Lymphohistiocytosis, Hemophagocytic / drug therapy
Lymphohistiocytosis, Hemophagocytic / etiology
Lymphohistiocytosis, Hemophagocytic / physiopathology
Lymphohistiocytosis, Hemophagocytic / virology*
Male
Oseltamivir / therapeutic use
Pandemics*

Substances

Antiviral Agents
Oseltamivir